中国的新冠疫苗接种策略及其对全球疫情的影响。
China's COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic.
作者信息
Meng Zhigang, Shan Shoujin, Zhang Ruilian
机构信息
School of Marxism, Hohai University, Nanjing, 211100, People's Republic of China.
North China University of Water Resources and Electric Power, Henan, Zhengzhou, 450046, People's Republic of China.
出版信息
Risk Manag Healthc Policy. 2021 Nov 15;14:4649-4655. doi: 10.2147/RMHP.S338701. eCollection 2021.
Abstract
Public health crises are challenging for governments and health systems. Vaccines are a key solution to viruses, and immunization has always played a critical role during public health crises in the past century. In the context of coronavirus disease 2019 (COVID-19), we explore China's vaccination strategies and challenges. Accordingly, we identify the causes of the high vaccination rate in China, including technical and nontechnical factors. Considering the impact of China's high vaccination rate on the global pandemic, we argue that it has strengthened China's opportunities and capabilities to participate in global development, enhanced the equity of vaccines and given the world community more choices.
摘要
公共卫生危机对政府和卫生系统构成挑战。疫苗是应对病毒的关键解决方案，在过去一个世纪的公共卫生危机中，免疫接种一直发挥着至关重要的作用。在2019冠状病毒病（COVID-19）的背景下，我们探讨了中国的疫苗接种策略和挑战。据此，我们确定了中国高疫苗接种率的原因，包括技术和非技术因素。考虑到中国高疫苗接种率对全球疫情的影响，我们认为这增强了中国参与全球发展的机遇和能力，提高了疫苗的公平性，并为国际社会提供了更多选择。
相似文献
1
China's COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic.中国的新冠疫苗接种策略及其对全球疫情的影响。
Risk Manag Healthc Policy. 2021 Nov 15;14:4649-4655. doi: 10.2147/RMHP.S338701. eCollection 2021.
2
China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.中国的新冠疫情防控策略及其对全球大流行的影响。
Front Public Health. 2022 Mar 14;10:857003. doi: 10.3389/fpubh.2022.857003. eCollection 2022.
3
China's Vaccine Diplomacy and Its Implications for Global Health Governance.中国的疫苗外交及其对全球卫生治理的影响。
Healthcare (Basel). 2022 Jul 10;10(7):1276. doi: 10.3390/healthcare10071276.
4
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.新冠疫情下中国卫生信息化的发展、现状与挑战：评估与建议。
J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345.
5
China's community-based crisis management model for COVID-19: A zero-tolerance approach.中国的社区层面新冠疫情危机管理模式：零容忍策略。
Front Public Health. 2022 Jul 22;10:880479. doi: 10.3389/fpubh.2022.880479. eCollection 2022.
6
Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.公共卫生危机比较：中国从 SARS 到 COVID-19 的疫情应对政策。
Glob Public Health. 2021 Aug-Sep;16(8-9):1223-1236. doi: 10.1080/17441692.2021.1919735. Epub 2021 Apr 23.
7
On the global COVID-19 pandemic and China's FDI.论全球新冠疫情与中国的外国直接投资
J Asian Econ. 2021 Jun;74:101300. doi: 10.1016/j.asieco.2021.101300. Epub 2021 Mar 18.
8
The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.中国疫情防控期间的法律制度对公共卫生和生活质量的影响：一项实证研究。
Int J Environ Res Public Health. 2022 Oct 20;19(20):13598. doi: 10.3390/ijerph192013598.
9
Evaluation of China's public health system response to COVID-19.评价中国公共卫生体系应对 COVID-19 的表现。
J Glob Health. 2021 Jan 16;11:05004. doi: 10.7189/jogh.11.05004.
10
Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.新冠疫情期间中国公共医疗机构的抗生素使用情况：基于2018 - 2020年全国采购数据的分析
Front Pharmacol. 2022 Feb 14;13:813213. doi: 10.3389/fphar.2022.813213. eCollection 2022.
引用本文的文献
1
Current landscape of innovative drug development and regulatory support in China.中国创新药物研发与监管支持的现状
Signal Transduct Target Ther. 2025 Jul 22;10(1):220. doi: 10.1038/s41392-025-02267-y.
2
Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.调查新冠疫情后对紧急使用授权疫苗的信心：以猴痘为例的假设情况。
PLoS Negl Trop Dis. 2025 May 29;19(5):e0013037. doi: 10.1371/journal.pntd.0013037. eCollection 2025 May.
3
Proposing a Novel Criterion for Achieving Herd Immunity in Global Epidemics (Pandemics): The Importance of Vaccination Velocity.提出全球流行病（大流行）中实现群体免疫的新准则：疫苗接种速度的重要性。
Iran J Public Health. 2024 Nov;53(11):2610-2612. doi: 10.18502/ijph.v53i11.16969.
4
Achilles' heel: elderly COVID-19 vaccination policy in China.阿喀琉斯之踵：中国老年人的 COVID-19 疫苗接种政策。
Health Res Policy Syst. 2024 Aug 5;22(1):90. doi: 10.1186/s12961-024-01155-1.
5
Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences.不同的新冠病毒群体免疫背景容忍不同的受体结合域（RBD）进化偏好。
Natl Sci Rev. 2024 Jun 5;11(7):nwae196. doi: 10.1093/nsr/nwae196. eCollection 2024 Jul.
6
HIV/AIDS, SARS, and COVID-19: the trajectory of China's pandemic responses and its changing politics in a contested world.艾滋病毒/艾滋病、严重急性呼吸综合征（SARS）和 COVID-19：中国应对大流行的轨迹及其在充满争议的世界中不断变化的政治。
Global Health. 2024 Jan 2;20(1):1. doi: 10.1186/s12992-023-01011-x.
7
Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China.在中国，调整“零新冠”策略后，老年人对接种疫苗的犹豫是否与心理健康有关？一项中介分析。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2288726. doi: 10.1080/21645515.2023.2288726. Epub 2023 Dec 6.
8
Impact of household decision makers' hesitancy to vaccinate children against COVID-19 on other household members: A family-based study in Taizhou, China.家庭决策者对儿童接种新冠疫苗的犹豫对其他家庭成员的影响：中国台州的一项基于家庭的研究
SSM Popul Health. 2023 Sep 21;24:101517. doi: 10.1016/j.ssmph.2023.101517. eCollection 2023 Dec.
9
The backfiring effects of monetary and gift incentives on Covid-19 vaccination intentions.货币和礼物激励对新冠疫苗接种意愿的适得其反效应。
China Econ Rev. 2023 Aug;80:102009. doi: 10.1016/j.chieco.2023.102009. Epub 2023 Jun 16.
10
Using Social Marketing to Promote COVID-19 Vaccination Uptake: A Case Study from the "AUBe Vaccinated" Campaign.利用社会营销促进新冠疫苗接种：“奥贝接种”活动的案例研究
Vaccines (Basel). 2023 Feb 16;11(2):459. doi: 10.3390/vaccines11020459.
本文引用的文献
1
Disparities in COVID-19 Vaccination among Low-, Middle-, and High-Income Countries: The Mediating Role of Vaccination Policy.低收入、中等收入和高收入国家在新冠疫苗接种方面的差异：疫苗接种政策的中介作用
Vaccines (Basel). 2021 Aug 14;9(8):905. doi: 10.3390/vaccines9080905.
2
The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria.漫长而曲折的道路：奥地利新冠疫苗接种的接受情况、可接受性及潜在影响因素
Vaccines (Basel). 2021 Jul 15;9(7):790. doi: 10.3390/vaccines9070790.
3
Efficiency in COVID-19 Vaccination Campaigns-A Comparison across Germany's Federal States.新冠疫苗接种活动的效率——德国联邦各州的比较
Vaccines (Basel). 2021 Jul 14;9(7):788. doi: 10.3390/vaccines9070788.
4
Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination.新冠疫苗犹豫的预测因素：社会人口统计学、合并症及过去的种族歧视经历
Vaccines (Basel). 2021 Jul 9;9(7):767. doi: 10.3390/vaccines9070767.
5
Willingness to Receive the COVID-19 and Seasonal Influenza Vaccines among the Saudi Population and Vaccine Uptake during the Initial Stage of the National Vaccination Campaign: A Cross-Sectional Survey.沙特人群中接种新冠病毒疫苗和季节性流感疫苗的意愿以及国家疫苗接种运动初始阶段的疫苗接种率：一项横断面调查
Vaccines (Basel). 2021 Jul 8;9(7):765. doi: 10.3390/vaccines9070765.
6
Antivaccine Movement and COVID-19 Negationism: A Content Analysis of Spanish-Written Messages on Twitter.反疫苗运动与新冠病毒否定论：对推特上西班牙语信息的内容分析
Vaccines (Basel). 2021 Jun 15;9(6):656. doi: 10.3390/vaccines9060656.
7
COVID-19 in Rural China: Features, Challenges and Implications for the Healthcare System.中国农村地区的新冠疫情：特点、挑战及对医疗系统的启示
J Multidiscip Healthc. 2021 May 6;14:1045-1051. doi: 10.2147/JMDH.S307232. eCollection 2021.
8
A global database of COVID-19 vaccinations.一个全球 COVID-19 疫苗接种数据库。
Nat Hum Behav. 2021 Jul;5(7):947-953. doi: 10.1038/s41562-021-01122-8. Epub 2021 May 10.
9
Willingness of Taiwan's Healthcare Workers and Outpatients to Vaccinate against COVID-19 during a Period without Community Outbreaks.台湾医护人员和门诊患者在无社区疫情期间接种新冠疫苗的意愿
Vaccines (Basel). 2021 Mar 12;9(3):246. doi: 10.3390/vaccines9030246.
10
COVID-19 Vaccine Acceptance among Health Care Workers in the United States.美国医护人员对新冠病毒疫苗的接受情况
Vaccines (Basel). 2021 Feb 3;9(2):119. doi: 10.3390/vaccines9020119.
Zotero 插件